BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 601876)

  • 1. Tamoxifen in disseminated breast cancer.
    Ferrazzi E; Cartei G; De Besi P; Fornasiero A; Palù G; Paccagnella A; Sperandio P; Fosser V; Grigoletto E; Fiorentino M
    Tumori; 1977; 63(5):463-8. PubMed ID: 601876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study.
    Campbell FC; Morgan DA; Bishop HM; Benton FM; Blamey RW; Elston CW; Nicholson RI; Griffiths K
    Clin Oncol; 1984 Jun; 10(2):111-5. PubMed ID: 6734002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy.
    Legha SS; Buzdar AU; Hortobagyi GN; Wiseman C; Benjamin RS; Blumenschein GR
    JAMA; 1979 Jul; 242(1):49-52. PubMed ID: 448865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of tamoxifen in patients with disseminated and local breast neoplasms].
    Semiglazov VF; Gershanovich ML; Kondrat'ev VB; Moiseenko VM
    Vopr Onkol; 1984; 30(9):39-43. PubMed ID: 6495691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen treatment of advanced breast carcinoma.
    Roesdahl K
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(3):203-8. PubMed ID: 93402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
    Carlson RW; Henderson IC
    Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen-induced endometrial cancer.
    Chen P; Yang CC; Chen YJ; Wang PH
    Eur J Gynaecol Oncol; 2003; 24(2):135-7. PubMed ID: 12701962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-oestrogen therapy of advanced mammary carcinoma.
    Westerberg H; Nordenskjöld B; de Schryver A; Notter G
    Acta Radiol Ther Phys Biol; 1976 Dec; 15(6):513-8. PubMed ID: 1031556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
    Morales L; Neven P; Timmerman D; Christiaens MR; Vergote I; Van Limbergen E; Carbonez A; Van Huffel S; Ameye L; Paridaens R
    Anticancer Drugs; 2004 Sep; 15(8):753-60. PubMed ID: 15494636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapy.
    De Lena M; Brambilla C; Jirillo A
    Tumori; 1980 Jun; 66(3):339-48. PubMed ID: 7445113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation.
    Lancet; 1983 Feb; 1(8319):257-61. PubMed ID: 6130291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of letrozole.
    Miller WR; Anderson TJ; Dixon JM
    Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
    Ellmén J; Hakulinen P; Partanen A; Hayes DF
    Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients.
    Gill BL; Simpson JF; Somlo G; McGonigle KF; Wilczynski SP
    Diagn Cytopathol; 1998 Dec; 19(6):417-22. PubMed ID: 9839130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy.
    Mourits MJ; Böckermann I; de Vries EG; van der Zee AG; ten Hoor KA; van der Graaf WT; Sluiter WJ; Willemse PH
    Br J Cancer; 2002 May; 86(10):1546-50. PubMed ID: 12085202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially.
    Powles TJ; Ashley S; Ford HT; Gazet JC; Nash AG; Neville AM; Coombes RC
    Lancet; 1984 Jun; 1(8391):1369-73. PubMed ID: 6145832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.